{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T12:01:51Z","timestamp":1649160111395},"reference-count":42,"publisher":"FapUNIFESP (SciELO)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq Bras Endocrinol Metab"],"published-print":{"date-parts":[[2007,7]]},"abstract":"<jats:p>O seguimento imediato ap\u00f3s tireoidectomia total (TT), em pacientes com c\u00e2ncer diferenciado de tire\u00f3ide (CDT), tradicionalmente \u00e9 feito com a abla\u00e7\u00e3o de remanescentes tireoidianos (RT) com 131I, na vig\u00eancia de hipotireoidismo. O seguimento tardio do CDT inclui o uso de doses supressivas de T4, dosagem seriada da tireoglobulina (Tg), pesquisa de corpo inteiro (PCI) com 131I e ultra-sonografia (US) cervical. Nos \u00faltimos anos, tem-se mostrado que a abla\u00e7\u00e3o de RT com a ajuda do TSH recombinante humano (rhTSH) tem a mesma efic\u00e1cia que a abla\u00e7\u00e3o de RT observada com a eleva\u00e7\u00e3o end\u00f3gena do TSH, mas sem os sintomas e piora de qualidade de vida descritos no hipotireoidismo. A dosagem da Tg estimulada com TSH end\u00f3geno ou ex\u00f3geno, 9 a 12 meses ap\u00f3s o tratamento inicial do CDT, associado \u00e0 US cervical, pode identificar pacientes de baixo risco potencialmente curados de sua doen\u00e7a e nos quais a supress\u00e3o do TSH n\u00e3o necessita ser t\u00e3o intensa, evitando as complica\u00e7\u00f5es card\u00edacas e \u00f3sseas da tireotoxicose ex\u00f3gena prolongada. Finalmente, apesar de n\u00e3o existirem estudos randomizados que avaliem o papel do rhTSH no tratamento do CDT metast\u00e1tico, os resultados do tratamento combinado do rhTSH e 131I mostram um benef\u00edcio cl\u00ednico na maioria dos pacientes tratados.<\/jats:p>","DOI":"10.1590\/s0004-27302007000500018","type":"journal-article","created":{"date-parts":[[2007,11,16]],"date-time":"2007-11-16T03:17:46Z","timestamp":1195183066000},"page":"806-812","source":"Crossref","is-referenced-by-count":3,"title":["Uso do TSH humano recombinante no c\u00e2ncer diferenciado de tire\u00f3ide"],"prefix":"10.1590","volume":"51","author":[{"given":"Hans","family":"Graf","sequence":"first","affiliation":[{"name":"Universidade Federal do Paran\u00e1"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilberto","family":"Paz-Filho","sequence":"additional","affiliation":[{"name":"Universidade Federal do Paran\u00e1"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"226","DOI":"10.7326\/0003-4819-126-3-199702010-00009","article-title":"Thyroid incidentalomas: Management approaches to nonpalpable nodules discovered incidentally on thyroid imaging","volume":"126","author":"Tan GH","year":"1997","journal-title":"Ann Intern Med","ISSN":"http:\/\/id.crossref.org\/issn\/0003-4819","issn-type":"print"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1056\/NEJMcp031436","article-title":"Clinical practice: The thyroid nodule","volume":"351","author":"Hegedus L","year":"2005","journal-title":"N Engl J Med","ISSN":"http:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref3","series-title":"Cancer Facts and Figures 2000-2005"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1089\/thy.2006.16.109","article-title":"Management guidelines for patients with thyroid nodules and differentiated thyroid cancer","volume":"16","author":"Cooper DS","year":"2006","journal-title":"Thyroid","ISSN":"http:\/\/id.crossref.org\/issn\/1050-7256","issn-type":"print"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1530\/eje.1.02158","article-title":"European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium","volume":"154","author":"Pacini F","year":"2006","journal-title":"Eur J Endocrinol","ISSN":"http:\/\/id.crossref.org\/issn\/0804-4643","issn-type":"print"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00000421-199802000-00018","article-title":"Use of radioactive iodine for thyroid remnant ablation in well-differentiated thyroid carcinoma to replace thyroid reoperation","volume":"21","author":"Lin JD","year":"1998","journal-title":"Am J Clin Oncol","ISSN":"http:\/\/id.crossref.org\/issn\/0277-3732","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1067\/msy.2001.118370","article-title":"Optimal treatment strategy in patients with papillary thyroid cancer: A decision analysis","volume":"130","author":"Esnaola NF","year":"2001","journal-title":"Surgery","ISSN":"http:\/\/id.crossref.org\/issn\/0039-6060","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4158\/EP.6.6.469","article-title":"Long-term outcome of patients with differentiated thyroid carcinoma: Effect of therapy","volume":"6","author":"Mazzaferri EL","year":"2000","journal-title":"Endocr Pract"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1089\/thy.1999.9.421","article-title":"An overview of the management of papillary and follicular thyroid carcinoma","volume":"9","author":"Mazzaferri EL","year":"1999","journal-title":"Thyroid","ISSN":"http:\/\/id.crossref.org\/issn\/1050-7256","issn-type":"print"},{"issue":"8","key":"ref10","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1210\/jc.2003-031167","article-title":"Clinical review 170: A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer","volume":"89","author":"Sawka AM","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1089\/thy.1997.7.613","article-title":"Quality-of-life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy","volume":"7","author":"Dow KH","year":"1997","journal-title":"Thyroid","ISSN":"http:\/\/id.crossref.org\/issn\/1050-7256","issn-type":"print"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1089\/thy.2005.15.1147","article-title":"Thyroid hormone withdrawal in patients with differentiated thyroid carcinoma: a one hundred thirty-patient pilot survey on consequences of hypothyroidism and a pharmacoeconomic comparison to recombinant thyrotropin administration","volume":"15","author":"Luster M","year":"2005","journal-title":"Thyroid","ISSN":"http:\/\/id.crossref.org\/issn\/1050-7256","issn-type":"print"},{"issue":"3","key":"ref13","first-page":"350","article-title":"Recombinant TSH in ablative therapy and follow-up of patients with differentiated thyroid carcinoma] 1","volume":"49","author":"Ros\u00e1rio PW","year":"2005","journal-title":"Arq Bras Endocrinol Metab"},{"issue":"9","key":"ref14","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1089\/thy.2000.10.767","article-title":"Using recombinant human TSH in the management of well-differentiated thyroid cancer: current strategies and future directions","volume":"10","author":"Mazzaferri EL","year":"2000","journal-title":"Thyroid","ISSN":"http:\/\/id.crossref.org\/issn\/1050-7256","issn-type":"print"},{"key":"ref15","series-title":"Basic & Clinical Endocrinology","volume-title":"The Thyroid Gland","author":"Greenspan FS","year":"2001","edition":"6th ed."},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1089\/thy.1999.9.447","article-title":"Development and in vitro characterization of human recombinant thyrotropin","volume":"9","author":"Weintraub BD","year":"1999","journal-title":"Thyroid","ISSN":"http:\/\/id.crossref.org\/issn\/1050-7256","issn-type":"print"},{"issue":"11","key":"ref17","first-page":"3877","article-title":"A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer","volume":"84","author":"Haugen BR","year":"1999","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1056\/NEJM199709253371304","article-title":"Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma","volume":"337","author":"Ladenson PW","year":"1997","journal-title":"N Engl J Med","ISSN":"http:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"issue":"11","key":"ref19","doi-asserted-by":"crossref","first-page":"5148","DOI":"10.1210\/jcem.86.11.8055","article-title":"Sudden enlargement of local recurrent thyroid tumor after recombinant human TSH administration","volume":"86","author":"Braga M","year":"2001","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"9","key":"ref20","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1210\/jc.2001-011918","article-title":"Ablation of thyroid residues with 30 mCi 131I: a comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal","volume":"87","author":"Pacini F","year":"2002","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1210\/jcem.86.2.7189","article-title":"Preparation by recombinant human thyrotropin or thyroid hormone withdrawal are comparable for the detection of residual differentiated thyroid carcinoma","volume":"86","author":"Robbins RJ","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"ref22","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1210\/jc.2003-030298","article-title":"Radioiodine treatment with 30 mCi after recombinant human thyrotropin stimulation in thyroid cancer: effectiveness for postsurgical remnants ablation and possible role of iodine content in L-thyroxine in the outcome of ablation","volume":"88","author":"Barbaro D","year":"2003","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1210\/jc.2005-1651","article-title":"Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study","volume":"91","author":"Pacini F","year":"2006","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1677\/erc.1.00830","article-title":"rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review","volume":"12","author":"Luster M","year":"2005","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"ref25","first-page":"648","article-title":"Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone","volume":"47","author":"Hanscheid H","year":"2006","journal-title":"J Nucl Med","ISSN":"http:\/\/id.crossref.org\/issn\/0161-5505","issn-type":"print"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1530\/eje.1.02223","article-title":"Cost-effectiveness of using recombinant human TSH prior to radioiodine ablation for thyroid cancer, compared with treating patients in a hypothyroid state: the German perspective","volume":"155","author":"Mernagh P","year":"2006","journal-title":"Eur J Endocrinol","ISSN":"http:\/\/id.crossref.org\/issn\/0804-4643","issn-type":"print"},{"key":"ref27","article-title":"Consenso brasileiro em n\u00f3dulos de tire\u00f3ide e c\u00e2ncer diferenciado de tire\u00f3ide, Departamento de Tire\u00f3ide - Sociedade Brasileira de Endocrinologia e Metabologia","volume":"51","author":"Maia AL","year":"2007","journal-title":"Arq Bras Endocrinol Metab"},{"issue":"236","key":"ref28","first-page":"31","article-title":"Resolu\u00e7\u00e3o RE n\u00ba 4.034","year":"2006","journal-title":"Di\u00e1rio Oficial da Uni\u00e3o"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/1097-0142(20000701)89:1<202::AID-CNCR27>3.0.CO;2-A","article-title":"Initial results from a prospective cohort study of 5, 583 cases of thyroid carcinoma treated in the united states during 1996: U. S. and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation study","volume":"89","author":"Hundahl SA","year":"2000","journal-title":"Cancer","ISSN":"http:\/\/id.crossref.org\/issn\/0008-543X","issn-type":"print"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2265.2004.02060.x","article-title":"Diagnostic value of serum thyroglobulin measurements in the follow-up of differentiated thyroid carcinoma, a structured meta-analysis","volume":"61","author":"Eustatia-Rutten CF","year":"2004","journal-title":"Clin Endocrinol"},{"issue":"4","key":"ref31","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1210\/jc.2002-021702","article-title":"A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma","volume":"88","author":"Mazzaferri EL","year":"2003","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"12","key":"ref32","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/00003072-200412000-00005","article-title":"Post I-131 therapy scanning in patients with thyroid carcinoma metastases: an unnecessary cost or a relevant contribution?","volume":"29","author":"Souza Ros\u00e1rio PW","year":"2004","journal-title":"Clin Nucl Med","ISSN":"http:\/\/id.crossref.org\/issn\/0363-9762","issn-type":"print"},{"issue":"5","key":"ref33","first-page":"909","article-title":"Follow-up of high-risk patients with differentiated thyroid cancer without persistent disease after initial therapy","volume":"50","author":"do Ros\u00e1rio PW","year":"2006","journal-title":"Arq Bras Endocrinol Metabol","ISSN":"http:\/\/id.crossref.org\/issn\/0004-2730","issn-type":"print"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1210\/jc.2003-031027","article-title":"Recombinant human thyrotropin stimulation of fluoro-D-glucose positron emission tomography uptake in well-differentiated thyroid carcinoma","volume":"89","author":"Chin BB","year":"2004","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00259-001-0745-6","article-title":"Influence of rhTSH on 18-fluorodeoxyglucose uptake by differentiated thyroid carcinoma","volume":"29","author":"Petrich T","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"ref36","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1210\/jc.2002-021925","article-title":"Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma","volume":"88","author":"Pacini F","year":"2003","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"7","key":"ref37","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1210\/jc.2003-031521","article-title":"Follow-up of low-risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph node metastases","volume":"89","author":"Torlontano M","year":"2004","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"4","key":"ref38","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1210\/jcem.86.4.7407","article-title":"Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer","volume":"86","author":"Mazzaferri EL","year":"2001","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1072-7515(03)00332-6","article-title":"\"Prognostic indicators of outcomes inpatients with distant metastases from differentiated thyroid carcinoma","volume":"197","author":"Shoup M","year":"2003","journal-title":"J Am Coll Surg","ISSN":"http:\/\/id.crossref.org\/issn\/1072-7515","issn-type":"print"},{"issue":"3","key":"ref40","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1046\/j.1365-2265.2002.01482.x","article-title":"Long-term follow-up of patients with bone metastases from differentiated thyroid carcinoma: surgery or conventional therapy?","volume":"56","author":"Zettinig G","year":"2002","journal-title":"Clin Endocrinol"},{"issue":"9","key":"ref41","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1445-5994.2006.01149.x","article-title":"Management of paediatric thyroidcarcinoma: recent experience with recombinant human thyroid stimulating hormone in preparation for radioiodine therapy","volume":"36","author":"Lau WF","year":"2006","journal-title":"Intern Med J"},{"issue":"11","key":"ref42","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1089\/thy.2006.16.1121","volume":"16","author":"Robbins RJ","year":"2006","journal-title":"Thyroid","ISSN":"http:\/\/id.crossref.org\/issn\/1050-7256","issn-type":"print"}],"container-title":["Arquivos Brasileiros de Endocrinologia &amp; Metabologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abem\/v51n5\/a18v51n5.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T20:15:23Z","timestamp":1495743323000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-27302007000500018&lng=pt&tlng=pt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0004-27302007000500018"],"URL":"https:\/\/doi.org\/10.1590\/s0004-27302007000500018","relation":{},"ISSN":["0004-2730"],"issn-type":[{"value":"0004-2730","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}